Guggenheim Capital’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-399,600
| Closed | -$11.3K | – | 1955 |
|
|
2024
Q2 | $11.3K | Hold |
399,600
| – | – | ﹤0.01% | 1855 |
|
|
2024
Q1 | $36K | Hold |
399,600
| – | – | ﹤0.01% | 1863 |
|
|
2023
Q4 | $42.1K | Hold |
399,600
| – | – | ﹤0.01% | 1866 |
|
|
2023
Q3 | $89.9K | Sell |
399,600
-39,560,400
| -99% | -$8.9M | ﹤0.01% | 1808 |
|
|
2023
Q2 | $0 | Buy |
39,960,000
+39,560,400
| +9,900% | – | ﹤0.01% | 1957 |
|
|
2023
Q1 | $71.9K | Buy |
399,600
+7,198
| +2% | +$1.3K | ﹤0.01% | 1895 |
|
|
2022
Q4 | $78.5K | Sell |
392,402
-4,869,298
| -93% | -$974K | ﹤0.01% | 1883 |
|
|
2022
Q3 | $0 | Sell |
5,261,700
-34,748,700
| -87% | – | ﹤0.01% | 2071 |
|
|
2022
Q2 | $0 | Buy |
40,010,400
+39,609,148
| +9,871% | – | ﹤0.01% | 2157 |
|
|
2022
Q1 | $353K | Hold |
401,252
| – | – | ﹤0.01% | 1814 |
|
|
2021
Q4 | $899K | Hold |
401,252
| – | – | ﹤0.01% | 1413 |
|
|
2021
Q3 | $1.36M | Buy |
+401,252
| New | +$1.36M | 0.01% | 1257 |
|